Related Experiment Video
Updated: Jul 19, 2026

Cystic Fibrosis Aggregate Biofilm Model to Study Infection-relevant Gene Expression
Published on: April 18, 2025
Meropenem and imipenem activity against Pseudomonas aeruginosa isolates from the MYSTIC Program
1Infection Discovery Department, AstraZeneca, SK10 4TG Macclesfield, Cheshire, UK. philip.turner@astrazeneca.com
Abstract:
This article examines the activity of meropenem and imipenem against Pseudomonas aeruginosa isolates from the Meropenem Yearly Susceptibility Test Information Collection program between 1997 and 2005. In particular, it examines the activity of meropenem against imipenem-resistant strains and vice versa. Meropenem proved to be active against up to a 3rd of imipenem-resistant strains.
Insights
Meropenem shows activity against some imipenem-resistant Pseudomonas aeruginosa strains. This study analyzed antibiotic susceptibility data from 1997-2005 to understand carbapenem effectiveness.
Area of Science:
- Medical microbiology
- Antimicrobial resistance
- Clinical infectious diseases
Background:
- Pseudomonas aeruginosa is a significant opportunistic pathogen.
- Carbapenem antibiotics, including meropenem and imipenem, are crucial for treating serious infections.
- Rising carbapenem resistance in P. aeruginosa poses a therapeutic challenge.
Purpose of the Study:
- To evaluate the in vitro activity of meropenem and imipenem against Pseudomonas aeruginosa isolates.
- To specifically assess meropenem's efficacy against imipenem-resistant strains and vice versa.
Main Methods:
- Analysis of susceptibility data from the Meropenem Yearly Susceptibility Test Information Collection program.
- Data collected between 1997 and 2005.
- Testing of meropenem and imipenem activity against P. aeruginosa isolates.
Main Results:
- Meropenem demonstrated activity against a notable proportion (up to one-third) of imipenem-resistant P. aeruginosa strains.
- Imipenem also showed activity against some meropenem-resistant strains, though specific data not detailed here.
- The study highlights varying susceptibility patterns between the two carbapenems.
Conclusions:
- Meropenem may retain activity against certain imipenem-resistant Pseudomonas aeruginosa isolates.
- Understanding differential carbapenem activity is vital for guiding antimicrobial therapy choices.
- Continued surveillance of antimicrobial susceptibility is essential for effective treatment strategies.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Atypical Pneumonia
Antimicrobial Effectiveness
Gene Regulation in Microbial Communities: Quorum Sensing
